Skip to main content

JANE STREET GROUP, LLC

Position in RGC — Regencell Bioscience Holdings Ltd

CIK 1595888 NEW YORK, NY

Position in RGC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$598,938
+$598,938 QoQ
Shares Held
98,348
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 35 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RGC Over Time

Shares Held

Position Value (USD)

Derivatives in RGC

reported options exposure · as of Jun 30, 2026
CallValue
$78,561
CallShares
12,900
PutValue
$396,459
PutShares
65,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $557,642,679 across 56 Drug Manufacturers - Specialty & Generic names. RGC ranks #24 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RGC

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $78,561 12,900
2026-06-30 $396,459 65,100
2026-06-30 $598,938 98,348
2026-03-31 $712,040 28,000
2025-12-31 $657,300 31,300
2025-09-30 $346,080 22,400
2025-09-30 $164,016 10,616
2025-09-30 $176,130 11,400